| Biotechnology feed | All feeds
27 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today that it has received a complete response letter from the U.S.
Food and Drug Administration (FDA) to its New Drug Application submitted in March 2009 for its ... Pharma Live: Jan 28 2010 5:21PM Matching: loestrin Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
